Oncology Case Examples
Drug-Disease Modeling Framework to Predict Clinical Endpoints
Predicting Phase 3 Survival Outcomes from Tumor Size Measurements in Phase 2
(presented at ASCPT 2010)
Exposure-Response Modeling to Inform Drug Label and Test Dosing Strategies
Impact of PK/PD Modeling and Simulation in Oncology: docetaxel (Taxotere) Case Study
Model-Based Predictions of Expected Anti-Tumor Response and Survival in Phase III Studies Based on Phase II Data of an Investigational Agent
(presented at 2006 ASCO Annual Meeting)